Margulies, David
- National Institute of Allergy and Infectious Diseases (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,842
- Rising Star
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$2M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#3,842
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Margulies, David as a PI. Multi-PI records show the full award amount for context.
- 1ZIAAI000622-32ZIAContact PIMolecular Interactions Of Lymphoid Cell Receptors$765.8Kaward amount
- 1ZIAAI000394-40ZIAContact PIMolecular Genetic Analysis Of Lymphocyte Function$765.8Kaward amount
- 1ZIAAI001028-16ZIAContact PIStructure and Function of Viral Immunoevasins$382.9Kaward amount
- 1ZIAAI001267-04ZIAContact PIRecombinant Engineering of SARS-CoV-2 Spike and N proteins$66.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Margulies, David as a PI.
FY2023 award administered by National Institute of Allergy and Infectious Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardNational Institute of Allergy and Infectious Diseases
- 2008$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #2382
- 2009Entered Top 25% NationallyRanked #2382
- 2011$5M Cumulative Funding
- 2014$10M Cumulative Funding
- 2023$25M Cumulative Funding